The UC Davis School of Medicine received $400 million in external research awards in fiscal year 2023-24. These federal, state and industry awards fund cutting edge medical and health research.
A new study is projecting that the number of people in the U.S. with atrial fibrillation, a common precursor to stroke, is about three times higher than previous estimates. An estimated 35% of people with a-fib will have a stroke.
An extra-long summer surge driven by new variants has prompted the early release of updated COVID-19 vaccines. A UCSF expert tells us what new vaccines could mean for the summer surge, who should get vaccinated, and when/where to get your vaccines.
UC Davis neurologist Ricardo Maselli will lead the first MDA Kickstart project to develop a gene therapy for a rare type of congenital myasthenic syndrome, an inherited neuromuscular disease.
Scientists discover how to drug GTPases, a group of 150 critical enzymes that act like "switches" in cells, which cause a wide variety of diseases such as cancer and Parkinson’s disease when mutated.
UCSF is collaborating with the SF Palliative Care Work Group to set up partnerships with local community groups to discuss advance care planning and palliative care. These community groups include churches, senior centers and organizations representing minority populations.
UC Davis Health has been designated a Center of Excellence becoming the eighth hospital in the U.S. to be recognized by the Wilson Disease Association.
Health Media Contacts
Find the best contact for health-related media inquiries.
